Titan Pharmaceuticals Inc (TTNP)
7.01
-0.09
(-1.27%)
USD |
NASDAQ |
Apr 18, 16:00
7.01
0.00 (0.00%)
After-Hours: 20:00
Titan Pharmaceuticals Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2020 | -0.54M |
| September 30, 2020 | -0.643M |
| June 30, 2020 | -0.26M |
| March 31, 2020 | -0.242M |
| December 31, 2019 | -0.256M |
| September 30, 2019 | -0.489M |
| June 30, 2019 | -0.446M |
| March 31, 2019 | -0.402M |
| December 31, 2018 | -0.416M |
| September 30, 2018 | -0.091M |
| June 30, 2018 | -0.202M |
| March 31, 2018 | -0.207M |
| December 31, 2017 | -0.175M |
| September 30, 2017 | -0.23M |
| June 30, 2017 | -0.149M |
| March 31, 2017 | -0.14M |
| December 31, 2016 | -0.171M |
| September 30, 2016 | -0.173M |
| June 30, 2016 | -0.172M |
| March 31, 2016 | -0.183M |
| December 31, 2015 | -0.133M |
| September 30, 2015 | -0.056M |
| June 30, 2015 | -0.017M |
| March 31, 2015 | -0.023M |
| December 31, 2014 | -0.018M |
| Date | Value |
|---|---|
| September 30, 2014 | -0.039M |
| June 30, 2014 | -0.03M |
| March 31, 2014 | -0.14M |
| December 31, 2013 | -0.318M |
| September 30, 2013 | -0.329M |
| June 30, 2013 | -0.463M |
| March 31, 2013 | -0.812M |
| December 31, 2012 | -1.154M |
| September 30, 2012 | -1.30M |
| June 30, 2012 | -1.167M |
| March 31, 2012 | -0.756M |
| December 31, 2011 | -0.234M |
| September 30, 2011 | -0.064M |
| June 30, 2011 | -0.071M |
| March 31, 2011 | -0.024M |
| December 31, 2010 | -0.028M |
| September 30, 2010 | -0.019M |
| June 30, 2010 | -0.012M |
| March 31, 2010 | -0.012M |
| December 31, 2009 | 0.002M |
| September 30, 2009 | 0.086M |
| June 30, 2009 | 0.107M |
| March 31, 2009 | 4.43M |
| September 30, 2008 | 12.63M |
| June 30, 2008 | 14.54M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.643M
Minimum
Sep 2020
-0.242M
Maximum
Mar 2020
-0.4109M
Average
-0.446M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
| Outset Medical Inc | 83.03M |
| Allurion Technologies Inc | -1.606M |
| AIM ImmunoTech Inc | -0.832M |
| Protalix BioTherapeutics Inc | -16.71M |
| Armata Pharmaceuticals Inc | -8.134M |